Effects of dynorphin A(1-13) on opiate withdrawal in humans.
S Specker, W Wananukul, D Hatsukami...
https://pubmed.ncbi.nlm.nih.gov/9676891Completed
Phase 2
Age: 18Years - 55Years
All Genders
ID00000244
Effects of Dynorphin 1-13 on Heroin Addiction
Led by University of Minnesota · Updated on 2015-05-27
N/A
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
U
University of Minnesota
Lead Sponsor
N
National Institute on Drug Abuse (NIDA)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to evaluate the effects of IV dynorphin in humans during acute heroin abstinence, in order to determine that dynorphin suppresses acute opiate withdrawal, reduces opiate craving, and is safe at doses required to produce the above effects.
CONDITIONS
Official Title
Effects of Dynorphin 1-13 on Heroin Addiction - 1
Who Can Participate
Age: 18Years - 55Years
All Genders
Eligibility Criteria
You may qualify if you...
opiate addict between the ages of 18-55
You will not qualify if you...
Regular abuse of other drugs, unstable medical conditions
Trial Site Locations
Total: 1 location
1
U of Minnesota School of Medicine
Minneapolis, Minnesota, United States, 55415
Status Unknown
Loading map...
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
N/A
Model
N/A
Primary Purpose
TREATMENT
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here